Shaileyee Das | Medicinal Chemistry | Women Researcher Award

Assoc Prof Dr. Shaileyee Das | Medicinal Chemistry | Women Researcher Award

 Associate Professor at Bharat Technology, India

Dr. Shaileyee Das is an Associate Professor and Head of the Department of Pharmacognosy, specializing in Natural Product Chemistry and its applications in pharmaceutical research. With a strong academic background and a diverse range of research interests, Dr. Das is committed to advancing knowledge in pharmacognosy, environmental protection, and sustainable development.

Author Metrics

ORCID Profile

Dr. Das has made significant contributions to the field of pharmaceutical sciences, evidenced by a substantial number of publications and patents. Her work includes innovative research in phytomedicine, nanotechnology, and the exploration of bioactive compounds from natural sources, which have garnered attention in various scientific communities.

Education

Dr. Das completed her Bachelor of Pharmacy (B. Pharm.) in 2011, followed by a Master of Pharmacy (M. Pharm.) in Pharmaceutical Chemistry in 2013, both from NSHM Knowledge Campus under Maulana Abul Kalam Azad University of Technology. She earned her Ph.D. in Pharmacy from Jadavpur University in 2022, focusing on the potential of biowastes in anticancer drug development.

Research Focus

Her research focuses on a multidisciplinary approach, including Natural Product Chemistry, Environmental Chemistry, and Nanoscience. Dr. Das is particularly interested in the isolation and characterization of bioactive compounds from freshwater algae and plants, as well as their implications for human health and environmental sustainability.

Professional Journey

Dr. Das began her career as a Microbiologist at Akansha Hair & Skin Herbals Pvt. Ltd. and has since held various academic positions, including Assistant Professor and currently Associate Professor at Bharat Technology. She has guided numerous M. Pharm. and B. Pharm. students in their research projects, emphasizing hands-on learning and innovation.

Honors & Awards

Dr. Das has received several awards throughout her career, including the Dr. Rabindra Debnath Memorial Best Research Initiative Award in 2024 and the Dr. P.D. Sethi Annual Award in 2014. Her academic excellence is highlighted by being the college topper during her M. Pharm. studies.

Publications Noted & Contributions

With over 20 published articles in reputable journals, Dr. Das has contributed to both pharmaceutical research and environmental protection. Her work addresses critical issues such as antimicrobial properties of plant extracts, the pharmacological potential of natural products, and innovative methods for waste management.

Studies of Chemical Distribution and Pharmacological Activities of Porifera-Derived Alkaloids: A Review (2000–2023)

Publication Details:

  • Journal: European Journal of Medicinal Chemistry Reports
  • Publication Date: August 2024
  • DOI: 10.1016/j.ejmcr.2024.100158
  • Contributors: Afsona Khatun, Kuntal Hazra, Belarani Mahato, Ritabrata Koley, Rajshekhar Ghorai, Anupam Adhikary, Biplab Debnath, Shaileyee Das

Overview

This comprehensive review examines the chemical distribution and pharmacological activities of alkaloids derived from Porifera (sponges) over a span of two decades (2000-2023). The work highlights the significance of these natural compounds in medicinal chemistry, focusing on their potential therapeutic applications.

Key Contributions

The collaborative effort from various researchers, including Dr. Shaileyee Das, underscores the growing interest in natural products as sources of bioactive compounds. The review consolidates existing knowledge and provides insights into future research directions in the field of pharmacognosy.

Relevance

This article is particularly relevant for researchers in medicinal chemistry, natural product research, and pharmacology, providing a valuable resource for understanding the therapeutic potential of Porifera-derived alkaloids.

Research Timeline

Dr. Das’s research journey began during her master’s program, with her Ph.D. focusing on biowastes for drug discovery. She has continued to expand her research portfolio through ongoing projects on freshwater algae and weeds, and has supervised multiple student research projects, contributing to knowledge in both academia and industry.

Conclusion

Dr. Shaileyee Das exemplifies a commitment to advancing pharmaceutical sciences through research, teaching, and community engagement. Her diverse expertise and passion for sustainable development make her a valuable asset to the academic and research community, paving the way for future innovations in pharmacognosy and environmental health.

Mei luo | Organic and organometallic chemistry | Best Researcher Award

Prof. Mei luo | Organic and organometallic chemistry | Best Researcher Award

Professor at Hefei university of technology, China 

Dr. Mei Luo is currently serving as an Associate Professor at Hefei University of Technology, bringing a wealth of experience in organic and organometallic chemistry. She obtained her Ph.D. from the University of Science and Technology of China and pursued postdoctoral research at prestigious institutions such as Peking University, the University of Utah, and the University of North Carolina at Chapel Hill. With a strong focus on synthesizing chiral organometallic complexes and drug synthesis, Dr. Luo has contributed significantly to the field through innovative research and academic endeavors.

Author Metrics

Scopus Profile

ORCID Profile

Dr. Mei Luo has achieved notable recognition in academia, boasting over 200 patents since 2006. Her research has been extensively published in reputable journals, highlighting her impact in the areas of metal complex synthesis, characterization, and their applications in medicinal chemistry and catalysis. Her publications reflect a strong interdisciplinary approach, integrating theoretical and experimental methodologies to advance the understanding and application of organometallic chemistry.

Dr. Mei Luo, currently affiliated with Hefei University of Technology in Hefei, China, has a notable academic profile. According to Scopus Author Identifier, her research has garnered 248 citations from 224 documents, with an h-index of 9. She has authored 62 documents indexed in Scopus, reflecting her significant contributions to the field of organic and organometallic chemistry. For more detailed metrics and information, accessing her full profile via Scopus or ORCID would provide comprehensive insights into her research impact and academic achievements.

Education

Dr. Luo earned her M.S. in Chemistry from Hefei University of Technology and completed her Ph.D. at the University of Science and Technology of China. Her academic journey also includes postdoctoral fellowships at Peking University, the University of Utah, and the University of North Carolina at Chapel Hill, where she further honed her expertise in organic and organometallic chemistry.

Research Focus

Dr. Mei Luo’s research primarily revolves around the synthesis of chiral organometallic complexes and drug synthesis. She has made significant contributions to understanding the structural and functional properties of metal complexes, particularly their applications in medicinal chemistry, catalysis, and molecular docking studies.

Professional Journey

Beginning with her educational background, Dr. Luo’s professional journey spans multiple prestigious institutions and positions. After completing her Ph.D., she conducted postdoctoral research at Peking University, the University of Utah, and the University of North Carolina at Chapel Hill. Currently, she serves as an Associate Professor at Hefei University of Technology, where she continues to lead research and mentor students in organic and organometallic chemistry.

Honors & Awards

Dr. Mei Luo has received recognition for her contributions to organic and organometallic chemistry, although specific awards and honors were not detailed in the provided information. Her extensive publication record and patent portfolio underscore her achievements and impact within her field of expertise.

Publications Noted & Contributions

Dr. Luo has authored numerous influential publications, focusing on metal complexes with biological applications. Notable publications include studies on the synthesis, characterization, and biological activities of Zn (II), Cu (II), Co (II), and Ni (II) complexes bearing aza-heterocyclic ligands, as well as their antitumor effects. Her research contributions extend to structural investigations, Hirshfeld surface analyses, and quantum mechanical studies of various organometallic compounds.

Mei Luo has authored several notable books and publications, including:

Zn (II), Cu (II), Co (II), and Ni (II) complexes bearing aza-heterocyclic ligands: synthesis, characterization, and anticancer activities

  • Journal: Journal of the Iranian Chemical Society
  • Date: 2024-06
  • DOI: 10.1007/s13738-024-03021-x
  • Contributors: Amir Nazeer, Qasim Umar, Yanting Yang, Mei Luo

A Brief Review: Advancement in the Synthesis of Amine through the Leuckart Reaction

Synthesis, characterization and anticancer activities of Zn2+, Cu2+, Co2+ and Ni2+ complexes involving chiral amino alcohols

  • Journal: RSC Advances
  • Date: 2022
  • DOI: 10.1039/D2RA05576G
  • Contributors: Qasim Umar, Y. H. Huang, Amir Nazeer, Hao Yin, Jing Cheng Zhang, Mei Luo, X. G. Meng

Correction to: One-step templated synthesis of chiral organometallic salicyloxazoline complexes

  • Journal: BMC Chemistry
  • Date: 2019-05-10
  • DOI: 10.1186/s13065-019-0577-8
  • Contributors: Mei Luo, Jing Cheng Zhang, Hao Yin, Cheng Ming Wang, Susan Morris-Natschke, Kuo-Hsiung Lee

One-step templated synthesis of chiral organometallic salicyloxazoline complexes

  • Journal: BMC Chemistry
  • Date: 2019-04-04
  • DOI: 10.1186/s13065-019-0565-z
  • Contributors: Mei Luo, Jing Cheng Zhang, Hao Yin, Cheng Ming Wang, Susan Morris-Natschke, Kuo-Hsiung Le

Research Timeline

Dr. Mei Luo’s research journey began with her doctoral studies at the University of Science and Technology of China, followed by postdoctoral research positions at Peking University, the University of Utah, and the University of North Carolina at Chapel Hill. Since joining Hefei University of Technology as an Associate Professor, she has continued to expand her research focus on chiral organometallic complex synthesis and drug synthesis, publishing extensively in respected scientific journals.

2024:

  1. Zn (II), Cu (II), Co (II), and Ni (II) complexes bearing aza-heterocyclic ligands: synthesis, characterization, and anticancer activities
    • This study focused on synthesizing and characterizing metal complexes with aza-heterocyclic ligands. It explored their potential anticancer activities, contributing to the field of medicinal chemistry and organometallic complexes.

2023:

  1. 一Research progress on one-pot synthesis of oxazoline metal complexes
    • This publication (translated as “Progress in One-Pot Synthesis of Oxazoline Metal Complexes”) discussed advancements in the one-pot synthesis method for creating oxazoline metal complexes, emphasizing efficiency and innovation in synthetic organic chemistry.
  2. Combining Effect of Zn2+, Cu2+, Co2+, and Ni2+ Complexes Containing Chiral Amino Alcohols: Synthesis, Characterization and their Anticancer Activities
    • This research delved into the synthesis and characterization of metal complexes containing chiral amino alcohols. It investigated their combined effects and anticancer activities, contributing valuable insights into the potential therapeutic applications of these complexes.

These recent achievements highlight Mei Luo’s ongoing contributions to the fields of organic synthesis, organometallic chemistry, and medicinal chemistry, particularly focusing on innovative synthesis methods and the development of compounds with significant biological activities.

Collaborations and Projects

Dr. Luo actively collaborates with researchers both nationally and internationally, enhancing her research impact and fostering interdisciplinary approaches in organic and organometallic chemistry. Her collaborations encompass projects that explore novel synthesis methodologies, structural characterization techniques, and the biological applications of metal complexes, contributing to advancements in medicinal chemistry and catalysis.